Sumitomo Mitsui Trust Holdings, Inc. Ironwood Pharmaceuticals Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 59,967 shares of IRWD stock, worth $257,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,967
Previous 55,867
7.34%
Holding current value
$257,858
Previous $486,000
19.75%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$98.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$92.7 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$70.5 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$39.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$38.3 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $659M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...